View
222
Download
0
Category
Preview:
Citation preview
8/8/2019 The PUMBA Gazette - November 2010 Edition
1/8
8/8/2019 The PUMBA Gazette - November 2010 Edition
2/8
The Editorial Address,
When social evils in India often revolved around children, be it
child marriage, child labour or female foeticide, Pandit
Jawaharlal Nehru, the first Prime Minister of independent India
loved children. A real visionary that he was, he had obviously
realized that the only way India could stride forward was bysecuring the lives of Indian kids. His birthday on 14
thNovember
is rightly celebrated as Childrens Day in India, hence this
edition.
The tie between a mother and her child is perhaps the
strongest of all, yet while building this bond, both have to go
through some of the most feeble and vulnerable phases of
their lives. As a believer of either science or mythology, one
cannot deny the fact that apposite care during the early
development of a new born, is vital for it to endure the
toughest of situations it may have to face later on in life.
From Mahabharata, where 7 infants were sacrificed before
Lord Krishna was born, till today, where India has amongst theworst infant mortality rates in the world, we have never had it
easy when it came to protecting the new borns.
In this edition of The PUMBA Gazette, we touch upon perhaps
the most delicate phase of human life- Infancy.
The news of pregnancy is always sweet for the parents-to-be.
But a bitter truth may await them if complications develop
during gestation. Gestational diabetes, unlike diabetes mellitus,
is not very well known but has been making its presence felt in
the recent past with increase in the number of cases. The
PUMBA Gazette team sought much needed information about
gestational diabetes by interviewing gynecologists from across
3 cities, namely Kolkata, Mumbai and Navi Mumbai, and Pune.The article included, focuses on awareness about gestational
diabetes, its existing tests for diagnosis and the treatment
adopted thereafter.
From the gestation period we move ahead with an article
about neonatal care. The article focuses on what has been
done and what needs to be done in India.
The Gazette then throws some light upon the innovations in
the field of biotechnology with an article about Stem cell
technology and its progress in the recent past. This is followed
by the news about recent happenings in the Biotechnology
industry.
The PUMBA Gazette team interviewed Mr. Vinod Narayanan
who manages the Export Operations at Phoenix Medical
Systems. Mr. Narayanan gave valuable insight into the niche
sector of Neonatal care industry in India. We wrap up the
November edition of the Gazette with PUMBA news that will
take you through the latest happenings in PUMBA.
I express sincere gratitude to the PUMBA Gazette team for
making my task easy by their sheer hard work and perfection.
Hope you enjoy reading the November edition as much as we
take pleasure in bringing it to you.
Sincerely yours,
Editor-in-chief:
Abhimanyu Tadwalkar (MBA-BT 2
nd
Year)The PUMBA Gazette Team
(The detailed project report shall be provided on enquiry.
Kindly send in your enquiries and feedback at
thepumbagazette@gmail.com)
Contents Cover Story 3
--Gestational Diabetes: When pregnancy is
not quite sweet a news!
Article 4
--Neonatal Care: Protecting the earliest
whispers of life
InnovEra 5
-- Systematic Therapies
The Industry Buzz 6-- Traditional Knowledge Database
Library: AN AID AGAINST BIOPIRACY
-- Sanofi to launch reusable insulin pens
-- Glenmark completes all phase III trials of
CROFELEMER
Candid Talk 7
-- Mr. Vinod Narayan on Neonatal
Intensive Care Units
PUMBA News 8
Another feather in the cap
-- The Race Begins
-- Get your Running shoes on
Celebrating Children's Day
mailto:thepumbagazette@gmail.com8/8/2019 The PUMBA Gazette - November 2010 Edition
3/8
Cover Story
GESTATIONAL DIABETES-
WHEN PREGNANCY IS NOT QUITE
SWEET A NEWS!
The uncharted facet in the spectrum of diabetes is gestational
diabetes mellitus. This condition is a form of diabetes which
affects pregnant women. The number of cases for gestational
diabetes mounting gradually made it the grounds for the
survey.
The hormones which are required for the development of
placenta block the action of insulin in the mothers body,
leading to a high glucose level. This condition is termed as
insulin resistance. When the body is unable to utilize glucose
due to insulin resistance, it results into gestational diabetes.
Gestational diabetes may affect the growth of the foetus.
Insulin does not cross the placenta like glucose. Extra blood
glucose passes from the mothers blood through the placenta
that gives the baby a high blood glucose level. It stimulates the
unborn baby's pancreas to make extra insulin in order to get rid
of the excess blood glucose. Since the baby gets more energy
than it needs to develop and grow, the extra energy is stored
as fat. This may lead to Macrosomia.
The study was conducted across 3 cities, namely Kolkata,
Mumbai and Navi Mumbai, and Pune. The study consisted of
interviewing gynecologists. The survey was conducted to
perceive the awareness about gestational diabetes, its existing
tests for diagnosis and the treatment adopted thereafter. Wealso endeavored to get knowledge about potential and
preferred course of treatment.
From the survey it emerged that, gestational diabetes was
observed in 2% of pregnancies. Majority of the doctors
interviewed were of the opinion that the level of awareness
about gestational diabetes among their patients was moderate.
They also commented that the level of awareness in case of
people belonging to lower economic strata of society was very
low. The most commonly used test for the diagnosis of
gestational diabetes was Glucose Tolerance Test (GTT) and the
other tests included Blood Sugar Level (BSL), Fasting PlasmaGlucose Test (FPG) and HbA1C test. The most common type of
GTT test done was oral GTT. 55% of the doctors were of the
opinion that diet cannot always control gestational diabetes.
However, the doctors in Kolkata were of the opinion t hat diet
has a major role to play in correction or prevention of the
condition.
The patients are required to take Insulin injections of
appropriate dosages; the dosage varying from case to case. The
most commonly prescribed insulin brand was found out to be
Mixtard (of NovoNordisk) followed by Glyciphage (of Franco
India), Novorapid (of NovoNordisk) and Huminsulin (of Eli Lilly).
Figure 1 TOMA of preferred tests for diagnosis of Gestational
Diabetes
In gestational diabetes, although the chances of the baby
becoming a diabetic later are very few, it can harm thedevelopment of the foetus, hence appropriate medications and
precautions need to be taken. 64% of the doctors interviewed
suggested that Oral drugs which are non-toxic to the baby;
preferably oral insulin should be introduced in the market. The
other suggestions included insulin pump, prick-free treatments,
nasal insulin and skin patches.
Figure 2. Most commonly Prescribed Brands
Initially, Metformin was not preferred by the gynecologists to
trim down the effect of elevated blood glucose level. This was
due to a speculated detrimental effect on the developing
foetus, but modern studies proved it incorrect. Thus, the
doctors took it as yet another potential form of medication
against gestational diabetes.
The companies should consider these views of the respondents
before launching new products in the market to treat
gestational diabetes.
Compiled by: Sumedh Purohit, Poorva Shinde, Firdaus Charanya
(MBA-BT, 2nd Year) Urmi Mukherjee, Vinay Pantulwar, Dhara Pujara,Neeraj Jadhav, Mrunmai Kulkarni, Harshal Kajale (MBA-BT 1
stYear)
1018
72
010203040
50607080
Blood Sugar Test FPG GTT
%ofRespondents
Most commonly used tests for Diagnosis
0
10
20
30
40
50
Huminsulin Novorapid Mixtard Glyciphage
Most commonly prescribed brands of Insulin
% of Respondents
8/8/2019 The PUMBA Gazette - November 2010 Edition
4/8
Article
NEONATAL CARE: PROTECTING THE
EARLIEST WHISPERS OF LIFE!A lack of skilled attendants at birth accounts for two million
preventable maternal deaths, stillbirths and newborn deaths
each year.
-Countdown to 2015 UNICEF Decade Report (2000-2010)
When a child is born, it certainly lights up the lives of many
around it. Hope, happiness and tears are all a part of childbirth.
The mother spends more than nine months of her life, nursing
her precious one inside. Therefore, it is only fair that her little
bundle of joy lives to have a full, happy life. However, a brightly
lit digital future that awaits us, miserably fails to meet this
simple expectation of a distraught new mother, for her
concerns do not touch us; she suffers in silence.
India has the unfortunate distinction of claiming more than a
quarter of the total newborn deaths in the world. Neonatal
Mortality is the death of a new born within a year of its birth.Although the Infant Mortality Rate (IMR) has gone down
considerably since the 1990s, the contribution of Neonatal
Mortality Rate (NMR) to IMR still remains high thereby
indicating that the reduction has been primarily due to a lower
post-natal mortality rate. The current NMR is approximately 44
out of every 1000 live births (44/1000), accounting for almost
two-thirds of infant mortality and one-half of under-5-years
mortality.
The NMR is also one and a half times higher in rural areas than
in urban areas. There is scientific evidence to suggest that
NMR, and hence IMR, can be significantly reduced by higherliteracy (especially female literacy) and better primary
healthcare services.
The major causes for neonatal deaths are prematurity/low
birth weight, birth asphyxia/injury and infection (sepsis,
pneumonia, diarrhoea). Around 33 percent of all neonates in
India are low-birth-weight (LBW), weighing less than 2500g.
Countdown to 2015
Nearly 50 percent of women in 68 countries mostly in sub-
Saharan Africa and South Asia give birth without a trained
nurse, midwife or doctor, according to the report, Countdown
to 2015, which tracks maternal health and newborn and child
survival during the decade from 2000 to 2010.
The report shows that only 10 countries have increased the
rate of skilled care at childbirth by 10 per cent or more since
1990; 11 countries have made no progress at all. And we make
it to the unwelcome list of these 11 countries!
What have we done?
The Government of India has integrated the Child Survival and
Safe Motherhood (CSSM) Programme since 1992 which aims to
provide essential newborn care, immunization, appropriate
management of diarrhea, acute respiratory infections, etc. for
children, as well as complimentary services to mothers.
The National Neonatology Forum is a non-governmental,academic organization, which has contributed by undertaking
country-wide training programs in neonatal care. In addition,
the Reproductive and Child Health Program II (RCH-II),
Integrated Management of Childhood Illness (IMCI) and
Integrated Management of Neonatal and Childhood Illness
(IMNCI), as well as the broader Indian National Rural Health
Mission launched in 2005, all aim to achieve a further,
significant reduction in the IMR, especially in the high IMR belt
that traverses the states of Orissa, Madhya Pradesh, Assam,
Bihar, Uttar Pradesh, Haryana and Rajasthan.
There has been a steady increase in the number of newborn
nurseries in the country, even though the total number of suchunits is still quite small. These nurseries still require adequate
infrastructure and staff including neonatal nurses, as well as
intensive care units.
What remains to be done?
While it is heartening that the Government of India has
responded by launching various programs to improve neonatal
care, it is clear that to make an impact in these states, specific
components of ante-natal, intra-natal and post-natal services
must be strengthened. Such services include the promotion of
timely and adequate infant immunization, growth monitoring,
care during diarrhoea and acute respiratory infections,
adequate breast-feeding and weaning supervision. To achieve
this goal, the existing primary healthcare system must be made
more accountable. It is also of extreme importance that
certain measures are taken to improve the awareness of
mothers and families regarding the care of normal and LBW
infants and the recognition of early signs of sickness.
While the total number of deaths in under-five children has
declined, the percentage of infants who die during the first 28
days after birth has increased in recent years, the report finds.
On a brighter note, provision of insecticide-treated bed nets (to
prevent malaria) and prevention of mother-to-child
transmission of HIV have been rapidly scaled up in many
countries. The success of these shows what can happen when
commitments are made and fulfilled.
UNICEF is emphasizing on reduction of under-five infant
mortality in their Millennium Development Goals 4, which
have to be met by 2015. These can only be achieved if
adequate funds are devoted. However, with the current trends
there will be a global gap of $60 billion in the funds. While a
number of programmes have been initiated to address the
issue of child health and mortality, all of them have only been
partially successful. It is evident that a lot more efforts have tobe taken not only by these organizations, but also by the
common people to work towards the improvement of neonatal
care.
We need more such commitments, with a focus on political,
economic, cultural and technological solutions to the crisis in
maternal and newborn health.
Compiled By: Nandini Sengupto and Neeraja Namboodiri (MBA-BT 2nd
Year)
8/8/2019 The PUMBA Gazette - November 2010 Edition
5/8
InnovEra
SYSTEMATIC THERAPIES
Stem cell biology is a promising and emerging field of the life
sciences. The potential of stem cell technology to develop
therapy for many untreatable diseases through cellular
replacement or tissue engineering is widely recognized.
Keeping in view its potential therapeutic applications, bothbasic and translational research are being promoted by the
departments in various institutions, hospitals and the industry.
Stem cell research is one such domain that has drawn
significant contribution from both public and private sectors.
The global market for stem cell therapy is expected to be
around US $ 88.3 billion by 2014 at CAGR OF 24.2% FOR 2009-
2014.Stem cell market in India has grown substantially and it is
estimated that India will have $2.4 billion market which is 2%
of total global market with highest CAGR of 27%.
Stem cells feature two important characteristics that make
them distinct from other cells. The first distinctive
characteristic is their ability to renew themselves through cell
division and the second is their capability of being induced to
become tissue or organic-specific cells with specific functions.
This capability of stem cells is used in treating various disorders
like Parkinsons disease, Alzheimers disease, diabetes, various
cardiac disorders, various types of cancers, orthopedics,
various ischemia disorders, etc. Stem cell research holds great
promise for improving human health by control of
degenerative disease and restoration of damaged organs whichare injured due to various injuries.
In treatment of Parkinsons disease, mesenchymal stem cells
are transplanted in brain through keyhole surgery. These stem
cells then multiply and thereby regenerate the damaged areas
of brain which leads to reactivation of brain resulting in
recovery from disease. The stem cells slow down or stop
further deterioration caused by the disease and it can also
reverse the effects of disease. The therapy is still considered
experimental as it is being tested in clinical trials and is not
available as standard medical treatment.
Stem cell therapy is also used in treating various types of
cancer. Stem cell treatments for cancer provide hope for many
patients suffering from some form of this disease. In fact, they
are already being used in certain types of cancer such as
leukemia. For years, stem cells have been used for treating
leukemia because it helps to restore the white and red blood
cells after high doses of radiation and chemotherapy are used.
They help because, stem cells have the ability to grow into
other cells, which means they can be used to replace damaged
and unhealthy cells with new healthy ones. Scientists believe
that these new healthy cells could be used as stem cell
treatments for cancer.
Doctors are using types of stem cell therapy for Alzheimers
already with excellent results thats paving the way for a
brighter future. Adult stem cell research has revealed some
possible cures for this condition. This process involves
collecting bone marrow from the patient that will be taken
from the hipbone. This bone marrow will be processed and
then the cells will be re-implanted back into the patient a few
days later. The cells that are placed back into the body have the
ability to transform into new cells that can replace or
rejuvenate the damaged nerves and tissues that cause this
disease. As a result, Alzheimers is slowed down considerably
and in some cases, it may stop the progression all together.
Even though the stem cell therapy may seem so promising,
there still many arguments going on whether stem cell therapy
should be used or not. The most debated issue is whether
using embryonic stem cells is ethical or not. One concern of
treatment is the possible risk that transplanted stem cells could
form tumors and have the possibility of becoming cancerous if
cell division continues uncontrollably.The challenges in this
area also include availability of human resource of desired
expertise; adequate infrastructure; interdisciplinary network of
researchers and clinicians for theme based research;
appropriate regulatory mechanisms; well defined basic
research leading to clinical/translational research, focused
centres and institutions.
But the benefits that stem cell therapy offers are more than
the controversies around it. It holds a great promise of
providing a better human life.
Compiled By: Hitesh Patil (MBA Biotechnology 2nd Year)
8/8/2019 The PUMBA Gazette - November 2010 Edition
6/8
The Industry Buzz
TRADITIONAL KNOWLEDGE
DATABASE LIBRARY: AN AID AGAINST
BIOPYRACY
The importance of the Traditional knowledge has once again
come into light. The piracy of the Traditional Knowledge andusing it for getting patents, commercializing the product, is also
called as Biopiracy. The US patent officers have planned a visit
in coming month to understand the Indian Traditional
Knowledge database that is available online.
A recent case of Biopiracy was reported and a suit was filed
against Colgate- Palmolive a FMCG giant in USA, for a patent
granted to them for a red herbal dentifrice. Some of the
companies in India including Dabur India and Shree Baidyanath
Ayurved Bhavan pvt Ltd have been selling the same
formulation for years in India under the brand name of Lal dantManjan.
There has been a strong opposition posted by these companies
with a claim that the red dentifrice has been known as
traditional knowledge in India since ages and thus cannot be
patented.
India and USA had previously signed an agreement to avoid the
misuse of traditional knowledge and wrongful issuance of
patents regarding same. However it could not be worked upon
because of operational difficulties.
Indian government in association with CSIR has started online
listing of traditional formulations known as Traditional
Knowledge Database Library. Till now the database contains 2,
23,000 medicinal formulations based on Ayurveda, Unani,
Siddha and Yoga systems. 28 patents granted before the
introduction of this database were cancelled by European
Patent Office after the introduction of the database. It is
estimated by TKDL that almost 2000 wrong patents can be
cancelled if they existed in traditional knowledge. A thorough
understanding of US Patent process by India and the sameunderstanding of TKDL by US authorities is needed.
The USPTO has expressed a concern over attempts of
traditional knowledge being patented with the removal of
knowledge from the public domain.
The step of TKDL is considered to be a positive step by the
industry people. According to them the TKDL would certainly
ensure that wrong patents are not issued and thus protection
of the traditional knowledge.
SANOFI TO LAUNCH REUSABLE
INSULIN PENSSanofi- Aventis is all set to roll out a very unique product in the
Indian market. The French Drug maker is launching a reusable
insulin pen in the Indian market in the coming next quarter 2 of
the year 2011.
The devise is in the advanced stage of development and will
soon be launched. According to the company it is totally an
Indianised version of the devise. The target market for the
company will be rural market. The reusable pen will be
launched keeping the focus on the rural market only. The
company is expecting one third of the sales to come from the
rural market. One of the factors is making the drugs available
to the Indian rural population at an affordable price.
The company is also ready to launch a cream of the Combiflam.
Combiflam is an OTC drug currently sold as tablet in the Indian
market as painkiller.
GLENMARK COMPLETES PHASE III
TRIALS FOR CROFELEMER.Glenmark, the Mumbai based drug maker has finally
completed the phase III trials of a new drug called Crofelemer.
It is a drug to be used against HIV associated Diarrhoea.
Glenmark has developed the drug in association with two other
foreign companies, namely Napo pharmaceuticals and SalixPharmaceuticals. Now company is lobbying for getting the
regulatory matters completed and making a way for the launch
of the drug. According to the sources the drug should be in
market in the year of 2012.
The company has all the rights to manufacture the active
ingredient. Glenmark will be the only supplier of this active
pharmaceutical ingredient. Also the marketing and distribution
rights remain with the company only for the drug to be
launched in total 140 countries.
Compiled by:Sumantsinh Girase (MBA Biotechnology 2nd Year)
8/8/2019 The PUMBA Gazette - November 2010 Edition
7/8
Candid Talk
Mr. VINOD NARAYAN ON NEONATAL
INTENSIVE CARE UNITS
Mr. Vinod Narayan manages the
Export Operations at Phoenix
Medical Systems-India which is thelargest Neonatal equipment
manufacturer. He has expanded the
overseas market for Phoenix
products to all major markets of
Latin America, Far East, Middle East,
CIS countries and European
countries.
Q.1. India accounts for more than a quarter of neonatal
mortality but the irony is that the Neonatal Care market is still
in the embryonic stage in India. What is your take on this?
The new born health challenge faced by India is bigger than
that experienced by any other country. Each year, 20 percentof the worlds infants an awesome 26 million are born in
this vast and diverse country. Of this number, 1.2 million die
before completing the first four weeks of life, a figure
amounting to 30 percent of the 3.9 million neonatal deaths
worldwide. India is home to the highest number of both births
and neonatal deaths of any country in the world. Neonatal
health among urban poor communities is emerging as a serious
problem. Most of the Indian neonatal mortality is in the rural
area and due to the cost involved in this, the advanced care
cannot be provided to all. The government is trying to set up
hospitals with advanced equipments but that would take time
and investment.
Q.2. What are the equipments available for neonatal care in
India and what additions are needed in Indian neonatal care
equipments market?
Indian markets even though not very well in the race with the
trends but still it is always updated about the new
developments in the segment and all new technologies are
always within reach the; only constraint being the fact that
importing material increases the cost and hence new
technologies take time to be introduced in the Indian Market.
The current Equipments available in this segment are:
Q.3. Do neonatal intensive care units (NICU) have a role in
developing countries like ours, taking into consideration the
fact that majority of babies have no access to primary care and
neonatal intensive care is among the more expensive services
that any health care system can provide?
The major factors determining the need for neonatal intensive
care services are population, birth rate, and proportion of live
births that are VLBW (i.e. less than 1,500 gm). The average stay
of a VLBW baby in the intensive care is around three weeks, soif we take 100 percent occupancy on all 365 days, we need
over 51,000 NICU beds committed to the care of these babies.
Data from developed countries show that VLBW infants
represent approximately 1.3 percent of births, but their need
for intensive care consumes 7 out of 10 intensive days. If we
take these factors into consideration, we may need over
72,000 neonatal NICU beds for the country. The existing
neonatal intensive care beds in the country at accredited units
today are less than 2,000, or less than three percent of the
requirement. So there is the need, but as said before the cost
of these services are high. Here the role of government and
private sector is important. The government should takemeasures to provide these services to common man at
reasonable cost and the primary care should always be given
the first priority. The private sector has equal role in providing
these services at reasonable cost.
Q.4. How important is it in maintaining customer relationship in
neonatal care equipment segment and what efforts go into
maintaining it?
If equipment is trouble free, you have a happy customer who
will come back to you for his/her future requirement and
happy customer means healthy consumer; this is what all
organization strive for in this segment. Providing good service
is imperative. There could be any kind of problem with theequipment and that may harm either the newborn or the
reputation of your customer therefore being in constant touch
with the customer and attending breakdown calls in the
shortest time is of utmost importance.
Q.5. How important is the technical expertise of the sales force
in the neonatal care segment?
Neonatal Care involves highly sophisticated instruments and
the operation of this instrument should be well known to the
sales force. They should be technically qualified to understand
the working and operations of the instruments. An under
qualified sales person who doesnt have knowledge about theproduct, either wont be able to sell the product or may create
a big, life threatening blunder. So the sales force should be
technically sound and understand the complete working of the
product.
Q.6. Analysis of a top market research firm shows that the
global market for neonatal diagnostics and monitoring is
estimated to reach $161.2million in 2012. What do you think
would be Indias contribution to this market?
Indias Contribution to this market by 2012 depends on the
international players coming to India and developing the
market. The potential is huge but the only requirement is the
proper harnessing of the available potential by both Domesticand International firms.
Compiled by:Tushar Pareek (MBA Biotechnology 2nd Year)
Comprehensive Infant Care
Center
Neonatal Open Care System
Infant Radiant Warmer Neonatal Intensive Care
Incubator
Neonatal Transport Incubator Neonatal Phototherapy Unit
Electronic Baby Weighing
Scale
Open Care Warmer
Delivery Table Resuscitating Bags
Nasal CPAP Infant Bassinets
Phototherapy Unit (PT-104) LED Phototherapy
Apnea Monitor Oxy Monitor
8/8/2019 The PUMBA Gazette - November 2010 Edition
8/8
The PUMBA News
ANOTHER FEATHER IN THE CAP
Dr. (Capt.) C.M. Chitale, former Dean, Faculty of Management
Studies, University of Pune, has been appointed as the new
Head of Department of PUMBA. Adding to his list of
achievements, he has also been nominated by Maratha
Chamber Of Commerce, Industries and Agriculture (MCCIA) on
various committees as
Special Invitee on Executive Committee
Co-Chairman on Education Committee
Member of HR Committee
Dr. (Capt) C. M. Chitale has always been a source of inspiration
and treasure of knowledge. The students will get to learn a lot
from his experiences in various fields.
THE RACE BEGINS...
The placement season for PUMBA MBA-BT course has
commenced from the month of November .The major
recruiters are Pharmaceutical, Biopharma and Biotech
industries while the other major recruiters being Biosuppliers,
Consultancies, Agriculture and Market Research firms from all
over India.
With optimism in the campus, students from various
backgrounds are eager to venture into the vast expanse of the
corporate.
A great placement season is expected ahead.
THE RUN FOR A CAUSE
25th
Pune International Marathon was organized on Sunday, 5th
December 2010. PUMBA has been a regular participant in Pune
International Marathon for the past few years and has been
regularly winning prizes like Best academic institution, Most
creative attire and Best slogans.
This year too, PUMBAites participated in the AIDS Charity Run
with zeal. More than 150 PUMBAites from first as well as
second year ran for a cause. Dr. (Capt.) C.M. Chitale, the Head
of the Department, enhanced the enthusiasm of the students
with his motivating speech. On 4th
December, PUMBAites
conducted an AIDS awareness campaign in the University
Campus and collected messages of professors and students for
the AIDS patients. Large banners with these messages were
then displayed at the Jawaharlal Nehru Stadium where the
marathon concluded. PUMBA won the Best Theme Award for
their AIDS awareness campaign.
Recommended